Page 348 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

326 PART III Therapeutic Modalities for the Cancer Patient

298. de Fornel-Thibaud P, Blanchard G, Escoffier-Chateau L, et al.: 320. Remillard RL, Saker KE: Critical care nutrition and enteral-assisted
Unusual case of osteopenia associated with nutritional calcium feeding. In Hand MS, Thatcher CD, Remillard RL, et al.: Small
and vitamin D deficiency in an adult dog, J Am Anim Hosp Assoc animal clinical nutrition, ed 5, Topeka, 2010, Mark Morris Insti-
VetBooks.ir 299. Taylor MB, Geiger DA, Saker KE, et al.: Diffuse osteopenia and 321. Wakshlag J, Schoeffler GL, Russell DS, et al.: Extravasation injury
tute, pp 477–491.
43:52–60, 2007.
myelopathy in a puppy fed a diet composed of an organic premix
trinomas, J Vet Emerg Crit Care 21:375–381, 2011.
and raw ground beef, J Am Vet Med Assoc 234:1041–1048, 2009. associated with parenteral nutrition in a cat with presumptive gas-
300. Michel KE, Sorenmo K, Shofer FS: Evaluation of body condition 322. Mauldin GE, Reynolds AJ, Mauldin GN, et al.: Nitrogen balance
and weight loss in dogs presented to a veterinary oncology service, in clinically normal dogs receiving parenteral nutrition solutions,
J Vet Intern Med 18:692–695, 2004. Am J Vet Res 62:912–920, 2001.
301. Kienzle E: Energy. In Beitz DC, editor: National Research Council 323. ASPEN Board of Directors and the Clinical Guidelines Task Force:
nutrient requirements of dogs and cats, ed 1, Washington DC, 2006, Guidelines for the use of parenteral and enteral nutrition in adult
National Academies Press, pp 28–48. and pediatric patients, JPEN J Parenter Enteral Nutr 26(Suppl
302. Remillard RL, Saker KE: Critical care nutrition and enteral-assisted 1):1SA–138SA, 2002.
feeding. In Hand MS, Thatcher CD, Remillard RL, et al.: Small 324. Gogos CA, Kalfarentzos F: Total parenteral nutrition and immune
animal clinical nutrition, ed 5, Topeka, 2010, Mark Morris Insti- system activity: a review, Nutrition 11:339–344, 1995.
tute, pp 441–476. 325. Kitchell CC, Balogh K: Pulmonary lipid emboli in association with
303. Delaney SJ: Management of anorexia in dogs and cats, Vet Clin long-term hyperalimentation, Hum Pathol 17:83–85, 1986.
North Am Small Anim Pract 36:1243–1249, 2006. 326. Thomovsky EJ, Backus RC, Mann FA, et al.: Effects of tempera-
304. Fox CB, Treadway AK, Blaszczyk AT, et al.: Megestrol acetate ture and handling conditions on lipid emulsion stability in veteri-
and mirtazapine for the treatment of unplanned weight loss in the nary parenteral nutrition admixured during simulated intravenous
elderly, Pharmacotherapy 29:383–397, 2009. administration, Am J Vet Res 69:652–658, 2008.
305. Zollers B, Wofford JA, Heinen E, et al.: A prospective, randomized, 327. Martin GJ, Rand JS: Food intake and blood glucose in normal and
masked, placebo-controlled clinical study of capromorelin indogs diabetic cats fed ad libitum, J Feline Med Surg 1:241–251, 1999.
with reduced appetite, J Vet Intern Med 30:1851–1857, 2016. 328. Ho VW, Leung K, Hsu A, et al.: A low carbohydrate, high protein
306. Quimby JM, Lunn KF: Mirtazapine as an appetite stimulant and diet slows tumor growth and prevents cancer initiation, Cancer Res
anti-emetic in cats with chronic kidney disease: a masked placebo- 71:4484–4493, 2011.
controlled crossover clinical trial, Vet J 197:651–655, 2013. 329. Nguyen P, Lerray V, Dumon H, et al.: High protein intake affects
307. Long JP, Greco SC: The effect of propofol administered intrave- lean body mass but not energy expenditure in nonobese neutered
nously on appetite stimulation in dogs, Contemp Top Lab Anim Sci cats, J Nutr 134:2084S–2086S, 2004.
39:43–46, 2000. 330. Hannah SS, LaFlamme DP: Effect of dietary protein on nitrogen
308. Salinardi BJ, Harkin KR, Bulmer BJ, et al.: Comparison of com- balance and lean body mass in cats, Vet Clin Nutr 3:30, 1996.
plications of percutaneous endoscopic versus surgically placed 331. Burns RA, Milner JA: Effects of arginine on the carcinogenicity
gastrostomy tubes in 42 dogs and 52 cats, J Am Anim Hosp Assoc of 7,12-dimethylbenz(a)-anthracene and N-methyl-N-nitrosurea,
42:51–56, 2006. Carcinogenesis 5:1539–1542, 1984.
309. Yoshimoto SK, Marks SL, Struble AL, et al.: Owner experiences 332. Brittenden J, Heys SD, Ross J, et al.: Natural cytotoxicity in breast
and complications with home use of a replacement low profile gas- cancer patients receiving neoadjuvant chemotherapy: effects of
trostomy device for long-term enteral feeding in dogs, Can Vet J L-arginine supplementation, Eur J Surg Onc 20:467–472, 1994.
47:144–150, 2006. 333. Reynolds JV, Daly JM, Shou J, et al.: Immunologic effects of argi-
310. Hill RC: Physical activity and environment. In Beitz DC, editor: nine supplementation in tumor-bearing and non-tumor-bearing
National Research Council nutrient requirements of dogs and cats, ed hosts, Ann Surg 211:202–210, 1990.
1, Washington DC, 2006, National Academies Press, pp 258–312. 334. Wakshlag JJ, Kallfelz FA, Wakshlag RR, et al.: The effects of
311. Wakshlag JJ: Nutritional management of megaesophagus, Clin branched-chain amino acids on canine neoplastic cell proliferation
Brief Aug 59–62, 2009. and death, J Nutr 136:2007S–2010S, 2006.
312. Chandler ML, Payne-James JJ: Prospective evaluation of a periph- 335. Kaufmann Y, Kornbluth J, Feng Z, et al.: Effect of glutamine on
erally administered three-in-one parenteral nutrition product in the initiation and promotion phases of DMBA-induced mammary
dogs, J Am An Hosp Assoc 47:518–523, 2006. tumor development, J Parenter Enteral Nutr 27:411–418, 2003.
313. Chan DL, Freeman LM, Labata MA, et al.: Retrospective evalua- 336. Yoshida S, Kaibara A, Ishibashi N, et al.: Glutamine supplementa-
tion of partial parenteral nutrition in dogs and cats, J Vet Int Med tion in cancer patients, J Nutr 17:766–768, 2001.
16:440–445, 2002. 337. Wigmore SJ, Barber MD, Ross JA, et al.: Effect of oral eicosapen-
314. Pyle SC, Marks SL, Kass PH: Evaluation of complications and taenoic acid on weight loss in patients with pancreatic cancer, Nutr
prognostic factors associated with administration of total paren- Cancer 36:177–184, 2000.
teral nutrition in cats: 75 cases (1994-2001), J Am Vet Med Assoc 338. Togni V, Ota CC, Folador A, et al.: Cancer cachexia and tumor
225:242–250, 2004. growth reduction in Walker 256 tumor-bearing rats supplemented
315. Crabb SE, Freeman LM, Chan DL, et al.: Retrospective evaluation with N-3 polyunsaturated fatty acids for one generation, Nutr Can-
of total parenteral nutrition in cats: 40 cases (1991-2003), J Vet cer 46:52–58, 2003.
Emer Crit Care 16:S1–S26, 2006. 339. Fearon KC, Von Meyenfeldt MF, Moses AG, et al.: Effect of a
316. Lippert AC, Fulton RB, Parr RB: A retrospective study of the use of protein and energy dense N-3 fatty acid enriched oral supplement
total parenteral nutrition in dogs and cats, J Vet Int Med 7:52–64, 1993. on loss of weight and lean tissue in cancer cachexia: a randomized
317. Queau Y, Larsen JA, Kass PH, et al.: Factors associated with adverse double blind trial, Gut 52:1479–1486, 2003.
outcomes during parenteral nutrition administration in dogs and 340. Colas S, Paon L, Denis F, et al.: Enhanced radiosensitivity of rat
cats, J Vet Intern Med 25:446–452, 2011. autochthonous mammary tumors by dietary docosahexaenoic acid,
318. Qin HL, Su ZD, Hu LG, et al.: Effect of early intrajejunal nutri- Int J Cancer 109:449–454, 2004.
tion on pancreatic pathological features and gut barrier function in 341. Senzaki H, Iwamoto S, Ogura E, et al.: Dietary effects of fatty
dogs with acute pancreatitis, Clin Nutr 21:469–472, 2002. acids on growth and metastasis of KPL-1 human breast cancer cells
319. Chan DL: Parenteral nutritional support. In Ettinger SL, Feldman in vivo and in vitro, Anticancer Res 18:1621–1627, 1998.
EC, editors: Textbook of veterinary internal medicine, ed 6, St. Louis, 342. Noguchi M, Earashi M, Minami M, et al.: Effects of eicosapentae-
2005, Elsevier Saunders, pp 586–591. noic and docosahexaenoic acid on cell growth and prostaglandin